Gene · 8754
Papers1,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Significance cytokines in immuno oncology and immunotherapy. | Transl Oncol | 2025 | 41167916 | PubTator, text mining | PubMed |
| ADAM9 drives PD-L1 shedding via IL-6 suppression and exploring therapeutic role of Bufalin treatment in hepatocellular carcinoma. | Discov Oncol | 2025 | 41160209 | PubTator, text mining | PubMed |
| The Role of ADAM9 and MMP9 in Diabetic Retinopathy: Insights from Ocular Parameters. | Int J Mol Sci | 2025 | 40943358 | PubTator, text mining | PubMed |
| SputOMICs identifies common and distinct markers in cystic fibrosis and chronic obstructive pulmonary disease. | Res Sq | 2025 | 40894026 | PubTator, text mining | PubMed |
| Bladder Cancer: Role of Circular RNAs in Oncogenesis, Tumor Suppression, and Therapeutic Target Identification. | Cancer Genomics Proteomics | 2025 | 40883021 | PubTator, text mining | PubMed |
| The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells. | Elife | 2025 | 40878909 | PubTator, text mining | PubMed |
| STN1 facilitates metastasis by promoting transcription of EMT-activator ZEB1 in pancreatic cancer. | Nat Commun | 2025 | 40841373 | PubTator, text mining | PubMed |
| The diagnostic value of LncRNA NEAT1 targeting miR-129-5p in pancreatic cancer patients. | Sci Rep | 2025 | 40730640 | PubTator, text mining | PubMed |
| Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment. | Biology (Basel) | 2025 | 40723400 | PubTator, text mining | PubMed |
| Interaction networks among miRNA, protein, and metabolite fingerprints identify the regulatory networks and key players in the pathogenesis of diabetic cardiomyopathy. | Front Cell Dev Biol | 2025 | 40661146 | PubTator, text mining | PubMed |
| Clinical Validation of ADAM9 as a Prognostic Biomarker in Oral Cancer. | Oral Dis | 2025 | 40523161 | PubTator, text mining | PubMed |
| Potential Influence of ADAM9 Genetic Variants and Expression Levels on the EGFR Mutation Status and Disease Progression in Patients with Lung Adenocarcinoma. | Int J Mol Sci | 2025 | 40429751 | PubTator, text mining | PubMed |
| ADAM Proteases in Cancer: Biological Roles, Therapeutic Challenges, and Emerging Opportunities. | Cancers (Basel) | 2025 | 40427200 | PubTator, text mining | PubMed |
| First Insights Into the Phenotype and Genotype of Inherited Retinal Disorders in the Democratic Republic of Congo (DRC). | Ann Hum Genet | 2025 | 40377368 | PubTator, text mining | PubMed |
| RETRACTION: LncRNA NEAT1 Targets MiR-125/ADAM9 Mediated NF-κB Pathway in Inflammatory Response of Rosacea. | Skin Res Technol | 2025 | 40371761 | PubTator, text mining | PubMed |
| ADAM9 Genetic Variants and Their Role in Modulating Enzyme Activity in Diabetes and Metabolic Traits. | J Diabetes Res | 2025 | 40330740 | PubTator, text mining | PubMed |
| Differential roles of the ADAM9/NF-κB and the ADAM9/STAT3 feedback loops in HIV-1 Tat-induced microglial inflammatory response and subsequent neuronal apoptosis. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40203953 | PubTator, text mining | PubMed |
| Bioinformatics analysis to identify environmental endocrine chemicals that target endometriosis genes. | Ecotoxicol Environ Saf | 2025 | 40187212 | PubTator, text mining | PubMed |
| Cyclic increase in the histamine receptor H1-ADAM9-Snail/Slug axis as a potential therapeutic target for EMT-mediated progression of oral squamous cell carcinoma. | Cell Death Dis | 2025 | 40113769 | PubTator, text mining | PubMed |
| ADAM9 mediates Cisplatin resistance in gastric cancer cells through DNA damage response pathway. | Med Oncol | 2025 | 40108033 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8754/papers?page=3